
Montelukast (10mg) + Levocetirizine (5mg)
Active composition
+1 more active ingredient
Montelukast selectively antagonizes leukotriene receptors, inhibiting their effects on bronchoconstriction and inflammation.
Levocetirizine selectively antagonizes H1 histamine receptors, inhibiting the effects of histamine in allergic responses.
Medical applications
Montidak Tablet is a combination medication containing Levocetirizine (5mg) and Montelukast (10mg), designed to provide relief from symptoms of allergies and asthma. Levocetirizine, an antihistamine, exhibits rapid and potent activity against histamine-induced responses, effectively alleviating symptoms such as itching, sneezing, and rhinitis. Montelukast, a leukotriene receptor antagonist, inhibits the action of leukotrienes, a group of potent chemical mediators involved in bronchoconstriction and inflammation, thereby reducing symptoms of asthma, such as wheezing, coughing, and shortness of breath. The combination of these two agents provides a comprehensive approach to managing allergic rhinitis and asthma, offering a broader range of therapeutic benefits. Montidak Tablet is indicated for the treatment of seasonal allergic rhinitis, perennial allergic rhinitis, and asthma, and is suitable for adults and children aged 12 years and above. It is administered orally, once daily, and can be taken with or without food.
How to use Montidak Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Montidak Tablet may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Caution is advised when consuming alcohol with Montidak Tablet. Please consult your doctor.
High Risk
Montidak Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Medical Advice
Montidak Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Montidak Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Montidak Tablet may be needed. Please consult your doctor. Limited information is available on the use of Montidak Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
Regular Checkup
Montidak Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Montidak Tablet should be used with caution in patients with kidney disease. Dose adjustment of Montidak Tablet may be needed. Please consult your doctor. Use of Montidak Tablet is not recommended in patients with severe kidney disease.
Regular Checkup
0 reviews for Montidak Tablet

Levocetirizine (5mg) + Montelukast (10mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Montelukast selectively antagonizes leukotriene receptors, inhibiting their effects on bronchoconstriction and inflammation.
Levocetirizine selectively antagonizes H1 histamine receptors, inhibiting the effects of histamine in allergic responses.
Medical applications
Montidak Tablet is a combination medication containing Levocetirizine (5mg) and Montelukast (10mg), designed to provide relief from symptoms of allergies and asthma. Levocetirizine, an antihistamine, exhibits rapid and potent activity against histamine-induced responses, effectively alleviating symptoms such as itching, sneezing, and rhinitis. Montelukast, a leukotriene receptor antagonist, inhibits the action of leukotrienes, a group of potent chemical mediators involved in bronchoconstriction and inflammation, thereby reducing symptoms of asthma, such as wheezing, coughing, and shortness of breath. The combination of these two agents provides a comprehensive approach to managing allergic rhinitis and asthma, offering a broader range of therapeutic benefits. Montidak Tablet is indicated for the treatment of seasonal allergic rhinitis, perennial allergic rhinitis, and asthma, and is suitable for adults and children aged 12 years and above. It is administered orally, once daily, and can be taken with or without food.
How to use Montidak Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Montidak Tablet may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Caution is advised when consuming alcohol with Montidak Tablet. Please consult your doctor.
High Risk
Montidak Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Medical Advice
Montidak Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Montidak Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Montidak Tablet may be needed. Please consult your doctor. Limited information is available on the use of Montidak Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
Regular Checkup
Montidak Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Montidak Tablet should be used with caution in patients with kidney disease. Dose adjustment of Montidak Tablet may be needed. Please consult your doctor. Use of Montidak Tablet is not recommended in patients with severe kidney disease.
Regular Checkup
0 reviews for Montidak Tablet















